Causal Network Modeling for Drug Mechanism Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for drug development struggle to accurately determine the biochemical pathways of drug mechanisms of efficacy and toxicity due to a lack of understanding of causal relationships between biomolecules, leading to inefficient drug candidate selection and limited predictive capabilities.
Innovation Solution
The development of data-driven systems and methods for deriving causal models of biological networks using probabilistic modeling frameworks, which reverse-engineer ensemble models from large datasets to infer causal relationships between variables such as compounds and biological markers, enabling the prediction of drug mechanisms and toxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional statistical methods (correlation analysis) are used to analyze biochemical data, then the analysis is simple and quick, but the ability to make formal predictions and understand causal relationships is lost
Solution Approach 1:
The patent replaces traditional statistical correlation analysis with causal modeling techniques that use probabilistic graphical models and intervention-based approaches. This substitution enables the system to infer causal relationships and make formal predictions about drug mechanisms, moving beyond mere association to understand underlying biological causality while maintaining computational efficiency.
Solution Approach 2:
The system transforms the analysis approach by changing from correlation-based parameters to causal parameters. By using do-calculus and intervention-based frameworks, the system can quantify causal effects of drug compounds on biochemical pathways, enabling predictive modeling of drug response and toxicity mechanisms that traditional correlation methods cannot achieve.
2Measurement precision
If computational approaches reverse engineer networks from molecular profiling data, then causal relationships can be inferred, but the mathematical complexity increases and the methods are limited to networks with very few components
Solution Approach 1:
The patent applies segmentation by breaking down the complex network analysis into modular components. The system analyzes individual biochemical pathways and molecular networks separately using causal modeling, then integrates these segmented analyses to understand broader drug mechanisms. This segmentation allows the system to handle large-scale biological networks without being overwhelmed by mathematical complexity.
Solution Approach 2:
The system introduces intermediary causal models that mediate between the raw molecular profiling data and the final drug mechanism predictions. These intermediary probabilistic graphical models simplify the mathematical relationships by representing causal structures in a standardized format, making the analysis tractable even for complex biological networks with many components.
3Adaptability or versatility
If current techniques are used to handle different types of data (gene expression, proteomic, metabalomic), then comprehensive analysis is possible, but the techniques are not equipped to simultaneously integrate these data types
Solution Approach 1:
The patent implements a universal causal modeling framework that can simultaneously integrate multiple data types including gene expression, proteomic, metabalomic, and phenotypic data. The system uses a unified probabilistic graphical model structure that accommodates different data modalities, allowing comprehensive analysis of drug mechanisms across multiple biological levels while maintaining reliable integration through standardized causal inference methods.
Data Source
AI summary
The systems and methods described herein utilize a probabilistic modeling framework for reverse engineering an ensemble of causal models, from data and then forward simulating the ensemble of models to analyze and predict the behavior of the network. In certain embodiments, the systems and methods described herein include data-driven techniques for developing causal models for biological networks. Causal network models include computational representations of the causal relationships between independent variables such as a compound of interest and dependent variables such as measured DNA alterations, changes in mRNA, protein, and metabolites to phenotypic readouts of efficacy and toxicity.